ISSUED: 4 June 2026
MEDIA CONTACT: Hans Fogle
SHEPHERDSTOWN, WV — Shepherd University Professor of Research Dr. Ann Liebert appeared on Fox Business’s Mornings with Maria on Thursday, June 4—to discuss emerging research on photobiomodulation (PBM) therapy and its potential to support brain health, treat traumatic brain injuries, and reduce the long-term effects of chronic traumatic encephalopathy (CTE).
During the interview, Liebert discussed growing evidence validating the use of specific wavelengths of red and near-infrared light to stimulate cellular energy production and support healing in the brain. The treatment, known as PBM, uses light to target mitochondria with the goal of improving cellular function and reducing inflammation.
The discussion highlighted recent research involving former National Football League players who participated in a 12-week study examining the effects of infrared light therapy on symptoms associated with CTE and other brain injuries. Researchers reported improvements in several measures of cognitive performance with no significant side effects.
Liebert explained that repeated concussions and other head injuries can contribute to long-term neurological conditions, including post-concussion syndrome, Parkinson’s disease, and CTE, a degenerative brain disease associated with repeated head trauma.
“Sports-related concussions can lead to a range of long-term brain health issues,” Liebert said during the interview. “We now have a treatment that has been increasingly validated and may not only help treat symptoms but potentially prevent some of these conditions from developing.”
Liebert also discussed Shepherd University’s ongoing research into concussion recovery and brain health. She noted that PBM therapy is showing promise not only for treating existing injuries but also as a potential preventative and neuroprotective intervention, particularly for younger athletes and individuals at risk of repeated head trauma.
In addition to concussion-related applications, Liebert discussed the broader implications of PBM for healthy aging and cognitive wellness. She explained that maintaining cellular energy production may help support brain function as people age and could play a role in addressing neurological conditions linked to inflammation and metabolic decline.
Shepherd University is a leader in PBM education and research through its Center of Excellence for Photobiomodulation, established in 2022. The Center supports research, clinical applications, and educational opportunities related to the use of red and near-infrared light therapies for neurological, inflammatory, and age-related conditions.
Shepherd researchers are currently collaborating with national and international partners on studies examining the potential of PBM therapy to support concussion recovery, brain health, and disease prevention. The University has also integrated PBM into its graduate nursing curriculum, providing students with exposure to emerging evidence-based therapies and their potential applications in healthcare.
To watch the full interview, visit: https://www.foxbusiness.com/video/6397530736112
— ### —
